327 related articles for article (PubMed ID: 19284928)
1. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
[TBL] [Abstract][Full Text] [Related]
6. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.
Brunner E; Tohen M; Osuntokun O; Landry J; Thase ME
Neuropsychopharmacology; 2014 Oct; 39(11):2549-59. PubMed ID: 24801768
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine/Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial.
Detke HC; DelBello MP; Landry J; Usher RW
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):217-24. PubMed ID: 25721187
[TBL] [Abstract][Full Text] [Related]
9. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
Andersen SW; Clemow DB; Corya SA
J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
[TBL] [Abstract][Full Text] [Related]
11. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine plus venlafaxine in treatment-resistant depression.
Devarajan S; Dursun SM
J Psychopharmacol; 2005 Jul; 19(4):434-5. PubMed ID: 15983004
[No Abstract] [Full Text] [Related]
13. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
Rothschild AJ; Williamson DJ; Tohen MF; Schatzberg A; Andersen SW; Van Campen LE; Sanger TM; Tollefson GD
J Clin Psychopharmacol; 2004 Aug; 24(4):365-73. PubMed ID: 15232326
[TBL] [Abstract][Full Text] [Related]
14. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
Zanarini MC; Frankenburg FR; Parachini EA
J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.
Bobo WV; Shelton RC
Expert Opin Pharmacother; 2009 Sep; 10(13):2145-59. PubMed ID: 19640209
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
Bobo WV; Shelton RC
Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
[TBL] [Abstract][Full Text] [Related]
17. Drug safety evaluation of olanzapine/fluoxetine combination.
Cristancho MA; Thase ME
Expert Opin Drug Saf; 2014 Aug; 13(8):1133-41. PubMed ID: 24972823
[TBL] [Abstract][Full Text] [Related]
18. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
Citrome L
Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
[TBL] [Abstract][Full Text] [Related]
20. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]